About Synteract
Synteract is a company based in Carlsbad (United States) founded in 1986 was acquired by Syneos Health in October 2020.. Synteract has raised $3 million across 1 funding round from investors including Syneos Health, Gryphon Investors and Amulet Capital. The company has 378 employees as of December 31, 2020. Synteract has completed 3 acquisitions, including Cu-Tech, Harrison Clinical Research and KinderPharm. Synteract operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Carlsbad, United States
- Employees 378 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synteract, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3 M (USD)
in 1 rounds
-
Latest Funding Round
$3 M (USD), Series A
Feb 28, 2014
-
Investors
Syneos Health
& 2 more
-
Employee Count
378
as on Dec 31, 2020
-
Investments & Acquisitions
Cu-Tech
& 2 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Synteract
Synteract has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in February 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $3.0M
-
First Round
First Round
(28 Feb 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2014 | Amount | Series A - Synteract | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Synteract
Synteract has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Syneos Health, Gryphon Investors and Amulet Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Amulet Capital is focused on healthcare private equity investments.
|
Founded Year | Domain | Location | |
|
CRO clinical development services are provided by Syneos Health.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Synteract
Synteract has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cu-Tech, Harrison Clinical Research and KinderPharm. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pediatric CRO services for drug development and formulations are specialized.
|
2014 | ||||
|
Global full-service CRO with operations in Europe, Israel and the USA (acquired by Synteract in 2013)
|
1999 | ||||
|
Full-service dermatology CRO for Phase I-IV clinical trials is operated.
|
1993 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Synteract
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synteract Comparisons
Competitors of Synteract
Synteract operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for cancer and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
CRO clinical development services are provided by Syneos Health.
|
|
| domain | founded_year | HQ Location |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| domain | founded_year | HQ Location |
Outsourced contract research organization services are provided to clients.
|
|
| domain | founded_year | HQ Location |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| domain | founded_year | HQ Location |
Global full-service CRO services are delivered in over 80 countries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synteract
Frequently Asked Questions about Synteract
When was Synteract founded?
Synteract was founded in 1986 and raised its 1st funding round 28 years after it was founded.
Where is Synteract located?
Synteract is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Is Synteract a funded company?
Synteract is a funded company, having raised a total of $3M across 1 funding round to date. The company's 1st funding round was a Series A of $3M, raised on Feb 28, 2014.
How many employees does Synteract have?
As of Dec 31, 2020, the latest employee count at Synteract is 378.
What does Synteract do?
In 2013, San Diego-based Synteract acquired Munich-based Harrison Clinical Research, forming SynteractHCR, an international contract research organisation. SynteractHCR is a global contract research organisation offering CRO services such as project management, clinical operations, medical writing, regulatory affairs and biostatistics etc., for phase I to phase IV research clinical trials. The therapeutic areas covered include oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory. The company claims to have conducted studies in 6 continents covering more than 60 countries. The company SynteractHCR was acquired by Amulet Capital Partners in May 2016.
Who are the top competitors of Synteract?
Synteract's top competitors include Emmes, Syneos Health and ClinChoice.
How many acquisitions has Synteract made?
Synteract has made 3 acquisitions, including Cu-Tech, Harrison Clinical Research, and KinderPharm.
Who are Synteract's investors?
Synteract has 3 investors. Key investors include Syneos Health, Gryphon Investors, and Amulet Capital.